Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02264678 |
Title | Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | AstraZeneca |
Indications |
triple-receptor negative breast cancer Her2-receptor negative breast cancer gastroesophageal junction adenocarcinoma |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | FRA |